Narrow search
Showing 1 - 10 of 3,030
Cover Image
The Effects of Detailing on Prescribing Decisions Under Quality Uncertainty
Ching, Andrew T.; Ishihara, Masakazu - 2010
manufacturers and physicians are uncertain about drug qualities. Our model assumes (i) a representative opinion leader is … (ii) manufacturers use detailing as a means to build/maintain the measure of physicians who are informed of the current … detailing to the current information sets and the measures of well-informed physicians. To illustrate the empirical implications …
Persistent link: https://www.econbiz.de/10014048404
Cover Image
Profit-seeking behavior of medical providers and generic competition in the pharmaceutical market : evidence from Taiwan
Liu, Ya Ming; Hsieh, Chee-Ruey - In: The B.E. journal of economic analysis & policy 14 (2014) 1, pp. 241-275
Persistent link: https://www.econbiz.de/10010345585
Cover Image
Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market
Bokhari, Farasat A. S.; Yan, Weijie - 2020
pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …
Persistent link: https://www.econbiz.de/10012285099
Cover Image
The effects of detailing on prescribing decisions under quality uncertainty
Ching, Andrew; Ishihara, Masakazu - In: Quantitative marketing and economics : QME 8 (2010) 2, pp. 123-165
Persistent link: https://www.econbiz.de/10003977328
Cover Image
Unintended Consequences of Products Liability : Evidence from the Pharmaceutical Market
Helland, Eric - 2014
In a complex economy, production is vertical and crosses jurisdictional lines. Goods are often produced by a global or national firm upstream and improved or distributed by local firms downstream. In this context, heightened products liability may have unintended consequences for consumer...
Persistent link: https://www.econbiz.de/10013056589
Cover Image
Unintended Consequences of Products Liability : Evidence from the Pharmaceutical Market
Helland, Eric - 2014
In a complex economy, production is vertical and crosses jurisdictional lines. Goods are often produced by a global or national firm upstream and improved or distributed by local firms downstream. In this context, heightened products liability may have unintended consequences for consumer...
Persistent link: https://www.econbiz.de/10012458659
Cover Image
Provider Incentives and Healthcare Costs : Evidence from Long-Term Care Hospitals
Einav, Liran - 2018
We study the design of provider incentives in the post-acute care setting - a high-stakes but under-studied segment of the healthcare system. We focus on long-term care hospitals (LTCHs) and the large (approximately $13,500) jump in Medicare payments they receive when a patient's stay reaches a...
Persistent link: https://www.econbiz.de/10012929197
Cover Image
The generics paradox revisited : empirical evidence from regulated markets
Vandoros, Sotiris; Kanavos, Panos - In: Applied economics 45 (2013) 22/24, pp. 3230-3239
Persistent link: https://www.econbiz.de/10010345456
Cover Image
Pharmaceutical prices: the impact of the launch strategy : an analysis of German data
Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012103333
Cover Image
Pharmaceutical prices : the impact of the launch strategy - an analysis of German data
Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019 - This Version: September 24, 2019
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012119750